Semi-Annual Consolidated Statement Of Income

株式会社PRISM BioLab - Filing #7333205

Concept 2023-10-01 to
2024-03-31
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2021-10-01 to
2022-09-30
2021-10-01 to
2022-09-30
2021-10-01 to
2022-09-30
2021-10-01 to
2022-09-30
Semi-annual consolidated statement of income
Statement of income
Net sales
115,482,000 JPY
112,926,000 JPY
554,396,000 JPY
Cost of sales
45,091,000 JPY
32,620,000 JPY
19,259,000 JPY
Gross profit (loss)
70,391,000 JPY
80,305,000 JPY
535,136,000 JPY
Ordinary profit (loss)
-322,855,000 JPY
-497,550,000 JPY
78,666,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
404,723,000 JPY
577,174,000 JPY
468,454,000 JPY
Extraordinary losses
12,593,000 JPY
28,154,000 JPY
4,508,000 JPY
Profit (loss) before income taxes
-335,448,000 JPY
-525,704,000 JPY
74,157,000 JPY
Operating profit (loss)
-334,331,000 JPY
-496,868,000 JPY
66,681,000 JPY
Income taxes - current
604,000 JPY
1,210,000 JPY
1,210,000 JPY
Non-operating income
Interest income
12,000 JPY
19,000 JPY
21,000 JPY
Non-operating income
16,726,000 JPY
89,000 JPY
13,960,000 JPY
Non-operating expenses
Non-operating expenses
770,000 JPY
1,976,000 JPY
Income taxes - deferred
JPY
-15,000 JPY
Income taxes
604,000 JPY
1,210,000 JPY
1,194,000 JPY
Profit (loss)
-336,052,000 JPY
-526,914,000 JPY
-526,914,000 JPY
-526,914,000 JPY
-526,914,000 JPY
72,962,000 JPY
72,962,000 JPY
72,962,000 JPY
72,962,000 JPY
Extraordinary losses
Impairment losses
12,593,000 JPY
28,151,000 JPY
4,508,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.